Which patients may benefit the most from topical roflumilast?
Featuring Raj Chovatiya, MD, PhD, MSCI | Associate Professor, Rosalind Franklin University of Medicine and Science, Chicago Medical School; Founder and Director,Center for Medical Dermatology + Immunology Research,Chicago, IL | Published October 28, 2022
Related Media
Powered by Polaris TM